273
Participants
Start Date
March 31, 2015
Primary Completion Date
June 7, 2019
Study Completion Date
June 7, 2019
Lenalidomide
In BMT CTN 0702, maintenance therapy with lenalidomide started at 10 mg daily for three months and increased to 15 mg daily. The duration of maintenance was three years in all treatment arms. Lenalidomide will be administered initially at the patient's last documented dose prior to discontinuation of BMT CTN 0702 lenalidomide maintenance therapy. Cycle duration is 28 days. Patients will continue lenalidomide until disease progression, or discontinuation due to toxicity, death, or withdrawal from the study.
Mount Sinai Medical Center, New York
Memorial Sloan-Kettering Cancer Center, New York
North Shore University Hospital, Lake Success
Roswell Park Cancer Center, Buffalo
Penn State College of Medicine, The Milton S. Hershey Medical Center, Hershey
University of Pennsylvania Cancer Center, Philadelphia
West Virginia University Hospital, Morgantown
Wake Forest University Health Sciences, Winston-Salem
Duke University Medical Center, Durham
BMT Group of Georgia (Northside Hospital), Atlanta
University of Florida College of Medicine, Gainesville
University of Miami, Miami
H. Lee Moffitt Cancer Center, Tampa
Sarah Cannon Blood & Marrow Transplant Program, Nashville
Ohio State/Arthur G. James Cancer Hospital, Columbus
Jewish Hospital BMT Program, Cincinnati
Karmanos Cancer Institute/BMT, Detroit
Medical College of Wisconsin, Milwaukee
University of Minnesota, Minneapolis
Rush University Medical Center, Chicago
Washington University, Barnes Jewish Hospital, St Louis
University of Kansas Hospital, Kansas City
Louisiana State University Health Sciences Center, Shreveport
University of Oklahoma Medical Center, Oklahoma City
University of Texas Southwestern Medical Center, Dallas
University of Texas/MD Anderson CRC, Houston
Texas Transplant Institute, San Antonio
Colorado Blood Cancer Institute, Denver
Arizona Cancer Center, Tucson
University of California, San Diego Medical Center, La Jolla
Stanford Hospital and Clinics, Stanford
City of Hope National Medical Center, Duarte
DFCI, Brigham and Womens Hospital, Boston
University of Michigan Medical Center, Ann Arbor
University of Nebraska Medical Center, Omaha
Hackensack University Medical Center, Hackensack
University of North Carolina Hospital at Chapel Hill, Chapel Hill
University Hospitals of Cleveland/Case Western, Cleveland
Oregon Health & Science University, Portland
Vanderbilt University Medical Center, Nashville
Fred Hutchinson Cancer Research Center, Seattle
University of Wisconsin Hospital & Clinics, Madison
Blood and Marrow Transplant Clinical Trials Network
NETWORK
National Cancer Institute (NCI)
NIH
National Marrow Donor Program
OTHER
National Heart, Lung, and Blood Institute (NHLBI)
NIH